Immuneering Corp Annual Cost of Revenue in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Immuneering Corp quarterly/annual Cost of Revenue history and growth rate from 2020 to 2023.
  • Immuneering Corp Cost of Revenue for the quarter ending December 31, 2023 was $0.000.
  • Immuneering Corp Cost of Revenue for the twelve months ending December 31, 2023 was $0.000, a 100% decline year-over-year.
  • Immuneering Corp annual Cost of Revenue for 2023 was $0.000, a 100% decline from 2022.
  • Immuneering Corp annual Cost of Revenue for 2022 was $158K, a 86.3% decline from 2021.
  • Immuneering Corp annual Cost of Revenue for 2021 was $1.15M, a 9.94% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 -$158K -100% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-01
2022 $158K -$995K -86.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-01
2021 $1.15M -$127K -9.94% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-06
2020 $1.28M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.